Cargando…
Increase in direct costs for health systems due to lupus nephritis: the case of Colombia
OBJECTIVE: Lupus nephritis is one of the most severe complications of systemic lupus erythematosus and it has been estimated that can occur in up to 60% of patients. Direct costs of lupus nephritis have not been studied in developing countries. This study aimed to describe lupus nephritis direct cos...
Autores principales: | Prada, Sergio I, Pérez, Ana M, Nieto-Aristizábal, Ivana, Tobón, Gabriel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018061/ https://www.ncbi.nlm.nih.gov/pubmed/35476081 http://dx.doi.org/10.31744/einstein_journal/2022AO6553 |
Ejemplares similares
-
Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020) -
Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers
por: Aguirre-Valencia, David, et al.
Publicado: (2019) -
Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018) -
Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases
por: Aguirre-Valencia, David, et al.
Publicado: (2019) -
Increased excretion of urinary podocytes in lupus nephritis
por: Bollain-y-Goytia, J. J., et al.
Publicado: (2011)